Health is one of the new paradigms of the insurance market and Cattolica Assicurazioni is well aware of it, which has just closed an agreement with the pharmaceutical company Roche Italia to have quick access to precision diagnostic services of Foundation Medicine (a company that is part of the Roche Group) in the oncology field, for its customers insured with the Active Wellness formula.
In the event of advanced or metastatic cancer, policyholders with the Veronese company will therefore be able to access the innovative diagnostic services and undergo a specific genomic profiling test which, by applying innovative NGS (Next Generation Sequencing) technologies, is able to identify any DNA mutations responsible for tumor development. On the basis of the genomic profile detected, it will thus be possible to obtain relevant information from a clinical point of view which will allow to personalize the care pathway, supporting the client in choosing the therapeutic treatment.
“The partnership with Roche Italia – comments Carlalberto Crippa, Business Development & Marketing Director of the Cattolica Group – offers the opportunity to provide Cattolica's customers with access to cutting-edge diagnostic services, identifying new parameters to get a broad overview the therapeutic opportunities available. In building our Health offer, we have chosen to combine prevention and protection by leveraging an ecosystem of partnerships that puts the health of the individual at the center and which, on a large scale, helps to generate well-being for the community. Roche, with Foundation Medicine, are important players in this ecosystem, because they allow us to enrich our offer with concrete solutions in a priority medical area such as oncology".
